why choose us

First received: November 14, 2022

Clinical Trial: Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay

Study Status: Completed

Recruit Status: RECRUITING

Condition: Bladder Cancer

Study Type: OBSERVATIONAL


Official Title: Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay in Subjects Suspected of Having Bladder Cancer

Brief Summary: The AnchorDx UriFind™ Bladder Cancer Assay is designed to detect 2 DNA methylation biomarkers in urine specimens from patients 22 years or older suspected of having bladder cancer.Results from the assay are intended for use, in conjunction with current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients.

Read more